Filtration Market (Focus on Biologics Manufacturing) - Distribution by Type of Filtration System (Depth Filtration, Tangential Flow Filtration, Virus Filtration and Other Membrane Filters), Type of Filter (based on use) (Disposable / Single use Filters and Reusable / Multi use Filters), Type of Assembly (Capsules, Cartridges and Others), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
The global filtration market is expected to reach USD 5.1 billion in 2023 anticipated to grow at a CAGR of 10% during the forecast period 2023-2035.
The healthcare sector has experienced remarkable expansion within the realm of biologics, emerging as one of its most rapidly growing segments. Over the past five years, the Food and Drug Administration (FDA) has approved more than 50 biologics for use, while nearly 10,000 others are progressing through diverse stages of assessment and development. This surge in demand for biologics has emphasized the critical need for advanced technologies dedicated to purifying these drug substances.
The inherent challenge stems from the delicate nature of biologics, which exhibit high sensitivity to heat and traditional chemical purification methods. These conventional treatments pose a risk of compromising the integrity of the final product by inducing degradation. Consequently, attention has shifted towards biopharmaceutical filtration, a purification and sterilization process that circumvents the use of heat and chemicals.
A significant breakthrough in this domain is the introduction of innovative filtration systems. These encompass depth filtration, tangential flow filtration, virus filtration, and chromatography filtration systems. Their adaptability enables application across a broad spectrum of uses. Major pharmaceutical entities have made substantial investments and advancements to enhance their conventional filtration technologies. The primary objective behind these advancements is to achieve the highest purity and yield of the desired biological product while ensuring its safety and efficacy for applications in human or animal health.
Given the continuous evolution of biologics, numerous companies have formulated and launched proprietary biopharmaceutical filtration systems. These systems are engineered specifically to efficiently purify biologics, catering to the evolving demands of the market. Essentially, the global filtration market stands poised for growth, predominantly driven by the escalating requirement for biologics.
Report Coverage
The healthcare sector has experienced remarkable expansion within the realm of biologics, emerging as one of its most rapidly growing segments. Over the past five years, the Food and Drug Administration (FDA) has approved more than 50 biologics for use, while nearly 10,000 others are progressing through diverse stages of assessment and development. This surge in demand for biologics has emphasized the critical need for advanced technologies dedicated to purifying these drug substances.
The inherent challenge stems from the delicate nature of biologics, which exhibit high sensitivity to heat and traditional chemical purification methods. These conventional treatments pose a risk of compromising the integrity of the final product by inducing degradation. Consequently, attention has shifted towards biopharmaceutical filtration, a purification and sterilization process that circumvents the use of heat and chemicals.
A significant breakthrough in this domain is the introduction of innovative filtration systems. These encompass depth filtration, tangential flow filtration, virus filtration, and chromatography filtration systems. Their adaptability enables application across a broad spectrum of uses. Major pharmaceutical entities have made substantial investments and advancements to enhance their conventional filtration technologies. The primary objective behind these advancements is to achieve the highest purity and yield of the desired biological product while ensuring its safety and efficacy for applications in human or animal health.
Given the continuous evolution of biologics, numerous companies have formulated and launched proprietary biopharmaceutical filtration systems. These systems are engineered specifically to efficiently purify biologics, catering to the evolving demands of the market. Essentially, the global filtration market stands poised for growth, predominantly driven by the escalating requirement for biologics.
Report Coverage
- An executive summary of the key insights captured in our research. It offers a high-level view on the current state of the biopharmaceutical filtration market and its likely evolution in the short to mid-term and long term.
- A general overview of biopharmaceutical filtration, highlighting details on the types of filtration systems and steps for sterile filtration for bioprocessing.
- A detailed assessment of the overall market landscape of the companies offering biopharmaceutical filtration systems, based on several relevant parameters, such as year of establishment, company size, location of headquarters, type of filter system / element and application area(s).
- A detailed competitiveness analysis of biopharmaceutical filtration system suppliers headquartered in North America, Europe and Asia-Pacific. The analysis compares the filtration system suppliers based on supplier strength and product strength.
- Detailed tabulated profiles of key players based in North America, Europe and Asia-Pacific and are engaged in manufacturing biopharmaceutical filtration systems (shortlisted based on company size and availability of financial information). Each profile includes a brief overview of the company, financial information, overview of product portfolio, recent developments and an informed future outlook.
- An in-depth analysis of various recent developments / trends related to biopharmaceutical filtration domain, offering insights on the patents that have been filed / granted for biopharmaceutical filters, since 2019, based on various relevant parameters, such type of patent, publication year, application year, type of applicant, emerging focus areas, geography, CPC symbols, leading players (in terms of number of patents granted / filed), patent benchmarking (in terms of CPC codes and leading players), patent characteristics and patent age. It also includes an insightful patent valuation analysis and list of leading patents by number of citations.
- A comprehensive market forecast analysis, highlighting the future potential of the market till 2035. We have segregated the current and upcoming opportunity based on type of filter system / element (depth filters, tangential flow filters, virus filters and other membrane filters), type of technology (disposable / single-use filters and reusable / multi-use filter), type of assembly (capsules, cartridges and others), company size (mid-sized / small and large), and key geographical regions (North America, Europe, Asia-Pacific and Rest of the World).
- Asahi Kasei
- Cobetter Filtration
- Corning
- Merck KGaA
- Pall Corporation (a company of Danaher Corporation)
- Parker Hannifin
- Sartorius
- Thermo Fisher Scientific
1. PREFACE
1.1. Chapter Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Filtration Systems
3.3. Types of Filtration Systems
3.4. Steps for Sterile Filtration for Bioprocessing
3.5. Factors Affecting Sterile Filtration
3.6. Advantages of Biopharmaceutical Filtration Systems
3.7. Challenges Associated with Biopharmaceutical Filtration Systems
3.8. Applications of Biopharmaceutical Filtration Systems
3.9. Conclusion
4. BIOPHARMACEUTICAL FILTRATION: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Biopharmaceutical Filtration System Developers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters (Region and Country-wise)
4.2.4. Analysis by Company size and Location of Headquarters
4.2.5. Analysis by Type of Filter System / Element
4.2.5.1. Depth Filtration Systems
4.2.5.1.1. Analysis by Type of Filter (based on use)
4.2.5.1.2. Analysis by Type of Media Material
4.2.5.1.3. Analysis by Type of Assembly
4.2.5.2. Tangential Flow Filtration / Crossflow Filtration Systems
4.2.5.2.1. Analysis by Type of Tangential Flow Filter (based on approach)
4.2.5.2.2. Analysis by Type of Filter (based on use)
4.2.5.2.3. Analysis by Type of Assembly
4.2.5.2.4. Analysis by Application Area(s)
4.2.5.3. Virus Filtration Systems
4.2.5.3.1. Analysis by Type of Product
4.2.5.3.2. Analysis by Application Area(s)
4.2.5.4. Other Membrane Filtration Systems
4.2.5.4.1. Analysis by Type of Filter (based on use)
4.2.5.4.2. Analysis by Type of Assembly
4.2.5.4.3. Analysis by Application Area(s)
4.2.6. Analysis by Novel Filtration Systems
4.2.7. Analysis by Type of Techniques(s) Used
4.2.8. Analysis by Application Area(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.3. Biopharmaceutical Filtration System Developers: Company Competitiveness
5.3.1. Players Headquartered in North America
5.3.2. Players Headquartered in Europe
5.3.3. Players Headquartered in Asia-Pacific and Rest of the World
6. DEVELOPERS HEADQUARTERED IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Corning
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. Pall Corporation
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Parker Hannifin
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Thermo Fisher Scientific
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Product Portfolio
6.5.4. Recent Developments and Future Outlook
7. DEVELOPERS HEADQUARTERED IN EUROPE AND ASIA-PACIFIC: COMPANY PROFILES
7.1. Chapter Overview
7.2. Merck
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Sartorius
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. Asahi Kasei
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Product Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. Cobetter Filtration
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
8. RECENT DEVELOPMENTS
8.1. Chapter Overview
8.2. Biopharmaceutical Filtration: Patent Analysis
8.2.1. Scope and Methodology
8.2.1.1. Analysis by Patent Publication Year
8.2.1.2. Analysis by Patent Jurisdiction
8.2.1.3. Analysis by CPC Symbols
8.2.1.4. Analysis by Emerging Focus Areas (Word Cloud)
8.2.1.5. Analysis by Type of Organization
8.2.1.6. Leading Industry Players: Analysis by Number of Patents
8.2.1.7. Leading Non-Industry Players: Analysis by Number of Patents
8.2.2. Biopharmaceutical Filtration: Patent Benchmarking Analysis
8.2.3. Analysis by Patent Characteristics
8.2.4. Biopharmaceutical Filtration: Patent Valuation Analysis
8.2.5. Analysis by Patent Age
8.2.6. Leading Patents: Analysis by Number of Citations
8.3 Biopharmaceutical Filtration: Mergers and Acquisitions
8.3.1. List of Mergers and Acquisitions
8.3.2. Cumulative Year-wise Distribution of Mergers and Acquisitions
8.3.3. Analysis by Deal Amount
8.3.4. Region Analysis
8.3.4.1. Intercontinental and Intracontinental Deals
8.3.5. Key Players: Analysis by Number of Deals
8.4. Concluding Remarks
9. GLOBAL EVENTS ANALYSIS
9.1. Chapter Overview
9.2. List of Global Events
9.2.1. Analysis by Year of Event
9.2.2. Analysis by Event Platform
9.2.3. Analysis by Type of Event
9.2.4. Analysis by Geography
9.2.5. Leading Event Organizers: Analysis by Number of Events
9.2.6. Analysis by Type of Filter (based on use) Involved
9.2.7. Analysis by Type of Filter System Involved
9.2.8. Analysis by Type of Process(es) Involved
9.2.9. Analysis by Application Area(s)
9.3. Concluding Remarks
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Biopharmaceutical Filtration Market, 2023-2035
10.3.1. Biopharmaceutical Filtration Market: Analysis by Type of Filter System, 2023 and 2035
10.3.1.1. Biopharmaceutical Filtration Market for Depth Filters, 2023-2035
10.3.1.2. Biopharmaceutical Filtration Market for Tangential Flow Filters, 2023-2035
10.3.1.3. Biopharmaceutical Filtration Market for Virus Filters, 2023-2035
10.3.1.4. Biopharmaceutical Filtration for Other Membrane Filters, 2023-2035
10.3.2. Biopharmaceutical Filtration Market: Analysis by Type of Filter (based on use), 2023 and 2035
10.3.2.1. Biopharmaceutical Filtration Market for Disposable / Single use Filters, 2023-2035
10.3.2.2. Biopharmaceutical Filtration Market for Reusable / Multi-use Filters, 2023-2035
10.3.3. Biopharmaceutical Filtration Market: Analysis by Type of Assembly, 2023 and 2035
10.3.3.1. Biopharmaceutical Filtration Market for Capsule Filters, 2023-2035
10.3.3.2. Biopharmaceutical Filtration Market for Cartridge Filters, 2023-2035
10.3.3.3. Biopharmaceutical Filtration Market for Other Filters, 2023-2035
10.3.3. Biopharmaceutical Filtration Market: Distribution by Company Size, 2023 and 2035
10.3.3.1. Biopharmaceutical Filtration Market for Mid-sized and Small Companies, 2023-2035
10.3.3.3. Biopharmaceutical Filtration Market for Large Companies, 2023-2035
10.3.4. Biopharmaceutical Filtration Market: Analysis by Key Geographical Regions, 2023 and 2035
10.3.4.1. Biopharmaceutical Filtration Market in North America, 2023-2035
10.3.4.1.1. Biopharmaceutical Filtration Market in North America: Analysis by Type of Filter System, 2023-2035
10.3.4.1.2. Biopharmaceutical Filtration Market in North America: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.1.3. Biopharmaceutical Filtration Market in North America: Analysis by Type of Assembly, 2023-2035
10.3.4.1.4. Biopharmaceutical Filtration Market in North America: Analysis by Company Size, 2023-2035
10.3.4.2. Biopharmaceutical Filtration Market in Europe, 2023-2035
10.3.4.2.1. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Filter System, 2023-2035
10.3.4.2.2. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.2.3. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Assembly, 2023-2035
10.3.4.2.4. Biopharmaceutical Filtration Market in Europe: Analysis by Company Size, 2023-2035
10.3.4.3. Biopharmaceutical Filtration Market in Asia-Pacific, 2023-2035
10.3.4.3.1. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Filter System, 2023-2035
10.3.4.3.2. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.3.3. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Assembly, 2023-2035
10.3.4.3.4. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Company Size, 2023-2035
10.3.4.4. Biopharmaceutical Filtration Market in Rest of the World, 2023-2035
10.3.4.4.1. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Filter System, 2023-2035
10.3.4.4.2. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Filter (based on use) , 2023-2035
10.3.4.4.3. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Assembly, 2023-2035
10.3.4.4.4. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Company Size, 2023-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Chapter Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Filtration Systems
3.3. Types of Filtration Systems
3.4. Steps for Sterile Filtration for Bioprocessing
3.5. Factors Affecting Sterile Filtration
3.6. Advantages of Biopharmaceutical Filtration Systems
3.7. Challenges Associated with Biopharmaceutical Filtration Systems
3.8. Applications of Biopharmaceutical Filtration Systems
3.9. Conclusion
4. BIOPHARMACEUTICAL FILTRATION: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Biopharmaceutical Filtration System Developers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters (Region and Country-wise)
4.2.4. Analysis by Company size and Location of Headquarters
4.2.5. Analysis by Type of Filter System / Element
4.2.5.1. Depth Filtration Systems
4.2.5.1.1. Analysis by Type of Filter (based on use)
4.2.5.1.2. Analysis by Type of Media Material
4.2.5.1.3. Analysis by Type of Assembly
4.2.5.2. Tangential Flow Filtration / Crossflow Filtration Systems
4.2.5.2.1. Analysis by Type of Tangential Flow Filter (based on approach)
4.2.5.2.2. Analysis by Type of Filter (based on use)
4.2.5.2.3. Analysis by Type of Assembly
4.2.5.2.4. Analysis by Application Area(s)
4.2.5.3. Virus Filtration Systems
4.2.5.3.1. Analysis by Type of Product
4.2.5.3.2. Analysis by Application Area(s)
4.2.5.4. Other Membrane Filtration Systems
4.2.5.4.1. Analysis by Type of Filter (based on use)
4.2.5.4.2. Analysis by Type of Assembly
4.2.5.4.3. Analysis by Application Area(s)
4.2.6. Analysis by Novel Filtration Systems
4.2.7. Analysis by Type of Techniques(s) Used
4.2.8. Analysis by Application Area(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.3. Biopharmaceutical Filtration System Developers: Company Competitiveness
5.3.1. Players Headquartered in North America
5.3.2. Players Headquartered in Europe
5.3.3. Players Headquartered in Asia-Pacific and Rest of the World
6. DEVELOPERS HEADQUARTERED IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Corning
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. Pall Corporation
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Parker Hannifin
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Thermo Fisher Scientific
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Product Portfolio
6.5.4. Recent Developments and Future Outlook
7. DEVELOPERS HEADQUARTERED IN EUROPE AND ASIA-PACIFIC: COMPANY PROFILES
7.1. Chapter Overview
7.2. Merck
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Sartorius
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. Asahi Kasei
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Product Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. Cobetter Filtration
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
8. RECENT DEVELOPMENTS
8.1. Chapter Overview
8.2. Biopharmaceutical Filtration: Patent Analysis
8.2.1. Scope and Methodology
8.2.1.1. Analysis by Patent Publication Year
8.2.1.2. Analysis by Patent Jurisdiction
8.2.1.3. Analysis by CPC Symbols
8.2.1.4. Analysis by Emerging Focus Areas (Word Cloud)
8.2.1.5. Analysis by Type of Organization
8.2.1.6. Leading Industry Players: Analysis by Number of Patents
8.2.1.7. Leading Non-Industry Players: Analysis by Number of Patents
8.2.2. Biopharmaceutical Filtration: Patent Benchmarking Analysis
8.2.3. Analysis by Patent Characteristics
8.2.4. Biopharmaceutical Filtration: Patent Valuation Analysis
8.2.5. Analysis by Patent Age
8.2.6. Leading Patents: Analysis by Number of Citations
8.3 Biopharmaceutical Filtration: Mergers and Acquisitions
8.3.1. List of Mergers and Acquisitions
8.3.2. Cumulative Year-wise Distribution of Mergers and Acquisitions
8.3.3. Analysis by Deal Amount
8.3.4. Region Analysis
8.3.4.1. Intercontinental and Intracontinental Deals
8.3.5. Key Players: Analysis by Number of Deals
8.4. Concluding Remarks
9. GLOBAL EVENTS ANALYSIS
9.1. Chapter Overview
9.2. List of Global Events
9.2.1. Analysis by Year of Event
9.2.2. Analysis by Event Platform
9.2.3. Analysis by Type of Event
9.2.4. Analysis by Geography
9.2.5. Leading Event Organizers: Analysis by Number of Events
9.2.6. Analysis by Type of Filter (based on use) Involved
9.2.7. Analysis by Type of Filter System Involved
9.2.8. Analysis by Type of Process(es) Involved
9.2.9. Analysis by Application Area(s)
9.3. Concluding Remarks
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Biopharmaceutical Filtration Market, 2023-2035
10.3.1. Biopharmaceutical Filtration Market: Analysis by Type of Filter System, 2023 and 2035
10.3.1.1. Biopharmaceutical Filtration Market for Depth Filters, 2023-2035
10.3.1.2. Biopharmaceutical Filtration Market for Tangential Flow Filters, 2023-2035
10.3.1.3. Biopharmaceutical Filtration Market for Virus Filters, 2023-2035
10.3.1.4. Biopharmaceutical Filtration for Other Membrane Filters, 2023-2035
10.3.2. Biopharmaceutical Filtration Market: Analysis by Type of Filter (based on use), 2023 and 2035
10.3.2.1. Biopharmaceutical Filtration Market for Disposable / Single use Filters, 2023-2035
10.3.2.2. Biopharmaceutical Filtration Market for Reusable / Multi-use Filters, 2023-2035
10.3.3. Biopharmaceutical Filtration Market: Analysis by Type of Assembly, 2023 and 2035
10.3.3.1. Biopharmaceutical Filtration Market for Capsule Filters, 2023-2035
10.3.3.2. Biopharmaceutical Filtration Market for Cartridge Filters, 2023-2035
10.3.3.3. Biopharmaceutical Filtration Market for Other Filters, 2023-2035
10.3.3. Biopharmaceutical Filtration Market: Distribution by Company Size, 2023 and 2035
10.3.3.1. Biopharmaceutical Filtration Market for Mid-sized and Small Companies, 2023-2035
10.3.3.3. Biopharmaceutical Filtration Market for Large Companies, 2023-2035
10.3.4. Biopharmaceutical Filtration Market: Analysis by Key Geographical Regions, 2023 and 2035
10.3.4.1. Biopharmaceutical Filtration Market in North America, 2023-2035
10.3.4.1.1. Biopharmaceutical Filtration Market in North America: Analysis by Type of Filter System, 2023-2035
10.3.4.1.2. Biopharmaceutical Filtration Market in North America: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.1.3. Biopharmaceutical Filtration Market in North America: Analysis by Type of Assembly, 2023-2035
10.3.4.1.4. Biopharmaceutical Filtration Market in North America: Analysis by Company Size, 2023-2035
10.3.4.2. Biopharmaceutical Filtration Market in Europe, 2023-2035
10.3.4.2.1. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Filter System, 2023-2035
10.3.4.2.2. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.2.3. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Assembly, 2023-2035
10.3.4.2.4. Biopharmaceutical Filtration Market in Europe: Analysis by Company Size, 2023-2035
10.3.4.3. Biopharmaceutical Filtration Market in Asia-Pacific, 2023-2035
10.3.4.3.1. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Filter System, 2023-2035
10.3.4.3.2. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.3.3. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Assembly, 2023-2035
10.3.4.3.4. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Company Size, 2023-2035
10.3.4.4. Biopharmaceutical Filtration Market in Rest of the World, 2023-2035
10.3.4.4.1. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Filter System, 2023-2035
10.3.4.4.2. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Filter (based on use) , 2023-2035
10.3.4.4.3. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Assembly, 2023-2035
10.3.4.4.4. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Company Size, 2023-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
